CaV1.2 β-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations

Excessive activation of calmodulin kinase II (CaMKII) causes arrhythmias and heart failure, but the cellular mechanisms for CaMKII-targeted proteins causing disordered cell membrane excitability and myocardial dysfunction remain uncertain. Failing human cardiomyocytes exhibit increased CaMKII and vo...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 107; no. 11; pp. 4996 - 5000
Main Authors Koval, Olha M, Guan, Xiaoquan, Wu, Yuejin, Joiner, Mei-ling, Gao, Zhan, Chen, Biyi, Grumbach, Isabella M, Luczak, Elizabeth D, Colbran, Roger J, Song, Long-Sheng, Hund, Thomas J, Mohler, Peter J, Anderson, Mark E
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 16.03.2010
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Excessive activation of calmodulin kinase II (CaMKII) causes arrhythmias and heart failure, but the cellular mechanisms for CaMKII-targeted proteins causing disordered cell membrane excitability and myocardial dysfunction remain uncertain. Failing human cardiomyocytes exhibit increased CaMKII and voltage-gated Ca²⁺ channel (CaV1.2) activity, and enhanced expression of a specific CaV1.2 β-subunit protein isoform (β₂a). We recently identified CaV1.2 β₂a residues critical for CaMKII phosphorylation (Thr 498) and binding (Leu 493), suggesting the hypothesis that these amino acids are crucial for cardiomyopathic consequences of CaMKII signaling. Here we show WT β₂a expression causes cellular Ca²⁺ overload, arrhythmia-triggering cell membrane potential oscillations called early afterdepolarizations (EADs), and premature death in paced adult rabbit ventricular myocytes. Prevention of intracellular Ca²⁺ release by ryanodine or global cellular CaMKII inhibition reduced EADs and improved cell survival to control levels in WT β₂a-expressing ventricular myocytes. In contrast, expression of β₂a T498A or L493A mutants mimicked the protective effects of ryanodine or global cellular CaMKII inhibition by reducing Ca²⁺ entry through CaV1.2 and inhibiting EADs. Furthermore, CaV1.2 currents recorded from cells overexpressing CaMKII phosphorylation- or binding-incompetent β₂a subunits were incapable of entering a CaMKII-dependent high-activity gating mode (mode 2), indicating that β₂a Thr 498 and Leu 493 are required for CaV1.2 activation by CaMKII in native cells. These data show that CaMKII binding and phosphorylation sites on β₂a are concise but pivotal components of a molecular and biophysical and mechanism for EADs and impaired survival in adult cardiomyocytes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: O.M.K., L.S.S., T.J.H., P.J.M., and M.E.A. designed research; O.M.K., X.G., Y.W., Z.G., B.C., T.J.H., and P.J.M. performed research; X.G., M.-L.J., Z.G., I.M.G., E.D.L., and R.J.C. contributed new reagents/analytic tools; O.M.K., Y.W., B.C., L.S.S., T.J.H., P.J.M., and M.E.A. analyzed data; and O.M.K., T.J.H., and M.E.A. wrote the paper.
Edited by Clara Franzini-Armstrong, University of Pennsylvania Medical Center, Philadelphia, PA, and approved February 2, 2010 (received for review November 30, 2009)
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0913760107